These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22798664)

  • 1. Genetic interdependence of Lyn and negative regulators of B cell receptor signaling in autoimmune disease development.
    Tsantikos E; Maxwell MJ; Kountouri N; Harder KW; Tarlinton DM; Hibbs ML
    J Immunol; 2012 Aug; 189(4):1726-36. PubMed ID: 22798664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A kinase-dead allele of Lyn attenuates autoimmune disease normally associated with Lyn deficiency.
    Verhagen AM; Wallace ME; Goradia A; Jones SA; Croom HA; Metcalf D; Collinge JE; Maxwell MJ; Hibbs ML; Alexander WS; Hilton DJ; Kile BT; Starr R
    J Immunol; 2009 Feb; 182(4):2020-9. PubMed ID: 19201855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of phosphoinositide 3-kinase δ signaling restrains autoimmune disease.
    Maxwell MJ; Tsantikos E; Kong AM; Vanhaesebroeck B; Tarlinton DM; Hibbs ML
    J Autoimmun; 2012 Jun; 38(4):381-91. PubMed ID: 22537464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of autoimmune disease in Lyn-deficient mice by the deletion of IL-5 receptor alpha chain gene.
    Moon BG; Takaki S; Nishizumi H; Yamamoto T; Takatsu K
    Cell Immunol; 2004 Apr; 228(2):110-8. PubMed ID: 15219462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity.
    Hibbs ML; Harder KW; Armes J; Kountouri N; Quilici C; Casagranda F; Dunn AR; Tarlinton DM
    J Exp Med; 2002 Dec; 196(12):1593-604. PubMed ID: 12486102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Interaction between Lyn, Ets1, and Btk in the Control of Antibody Levels.
    Mayeux J; Skaug B; Luo W; Russell LM; John S; Saelee P; Abbasi H; Li QZ; Garrett-Sinha LA; Satterthwaite AB
    J Immunol; 2015 Sep; 195(5):1955-63. PubMed ID: 26209625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perturbation of the CD4 T cell compartment and expansion of regulatory T cells in autoimmune-prone Lyn-deficient mice.
    Tsantikos E; Quilici C; Harder KW; Wang B; Zhu HJ; Anderson GP; Tarlinton DM; Hibbs ML
    J Immunol; 2009 Aug; 183(4):2484-94. PubMed ID: 19620313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6.
    Tsantikos E; Oracki SA; Quilici C; Anderson GP; Tarlinton DM; Hibbs ML
    J Immunol; 2010 Feb; 184(3):1348-60. PubMed ID: 20042579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.
    Jellusova J; Wellmann U; Amann K; Winkler TH; Nitschke L
    J Immunol; 2010 Apr; 184(7):3618-27. PubMed ID: 20200274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic evidence for Lyn as a negative regulator of IL-4 signaling.
    Janas ML; Hodgkin P; Hibbs M; Tarlinton D
    J Immunol; 1999 Oct; 163(8):4192-8. PubMed ID: 10510355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA4Ig alters the course of autoimmune disease development in Lyn-/- mice.
    Oracki SA; Tsantikos E; Quilici C; Light A; Schmidt T; Lew AM; Martin JE; Smith KG; Hibbs ML; Tarlinton DM
    J Immunol; 2010 Jan; 184(2):757-63. PubMed ID: 19966213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MyD88-dependent autoimmune disease in Lyn-deficient mice.
    Silver KL; Crockford TL; Bouriez-Jones T; Milling S; Lambe T; Cornall RJ
    Eur J Immunol; 2007 Oct; 37(10):2734-43. PubMed ID: 17853409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice.
    Nishizumi H; Taniuchi I; Yamanashi Y; Kitamura D; Ilic D; Mori S; Watanabe T; Yamamoto T
    Immunity; 1995 Nov; 3(5):549-60. PubMed ID: 7584145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of STAT6 promotes autoimmune disease and atopy on a susceptible genetic background.
    Lau M; Tsantikos E; Maxwell MJ; Tarlinton DM; Anderson GP; Hibbs ML
    J Autoimmun; 2012 Dec; 39(4):388-97. PubMed ID: 22867713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn- and CD22-independent pathways affecting BCR regulation and B cell survival.
    Ferry H; Crockford TL; Silver K; Rust N; Goodnow CC; Cornall RJ
    Eur J Immunol; 2005 Dec; 35(12):3655-63. PubMed ID: 16278813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abrogation of autoimmune disease in Lyn-deficient mice by the mutation of the Btk gene.
    Takeshita H; Taniuchi I; Kato J; Watanabe T
    Int Immunol; 1998 Apr; 10(4):435-44. PubMed ID: 9620599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-21 promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn-/- mice.
    Gutierrez T; Mayeux JM; Ortega SB; Karandikar NJ; Li QZ; Rakheja D; Zhou XJ; Satterthwaite AB
    Eur J Immunol; 2013 Feb; 43(2):382-93. PubMed ID: 23169140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling mutations and autoimmunity.
    Yu CC; Mamchak AA; DeFranco AL
    Curr Dir Autoimmun; 2003; 6():61-88. PubMed ID: 12408047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice.
    Hasegawa M; Fujimoto M; Poe JC; Steeber DA; Lowell CA; Tedder TF
    J Immunol; 2001 Sep; 167(5):2469-78. PubMed ID: 11509585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive and negative roles of the tyrosine kinase Lyn in B cell function.
    DeFranco AL; Chan VW; Lowell CA
    Semin Immunol; 1998 Aug; 10(4):299-307. PubMed ID: 9695186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.